Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AL › Birmingham › NPI 1154435824
Hospital

University of Alabama at Birmingham

University of Alabama at Birmingham was paid $19.18M by Medicaid between Jan 2018 and Nov 2024, across 262 billing codes. Its largest line is J0791, Injection, crizanlizumab-tmca, 5 mg — 31% of everything it billed.

33Billing provider infoUNIVERSITY OF ALABAMA AT BIRMINGHAM
BIRMINGHAM, AL 35249
33aNPI1154435824assigned 08/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.18M
24GClaims701,711
24DCodes billed262
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Alabama

Rank by total paid#1 of 77
Median peer was paid$1.13M
This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201888,648$1.48M
2019101,288$1.77M
202072,856$1.58M
2021118,914$3.54M
2022115,156$3.42M
2023121,682$4.14M
2024incomplete83,167$3.24M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0791 Injection, crizanlizumab-tmca, 5 mg 31% 1,027 864 $5.98M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 19% 98,345 91,680 $3.60M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.0% 17,398 16,691 $1.16M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 4.9% 24,450 23,536 $944K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.1% 12,668 11,868 $600K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.9% 66,718 60,640 $564K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 12,918 12,411 $543K
80048 Basic metabolic panel (calcium, ionized) 2.7% 50,566 47,388 $515K
36430 1.5% 2,528 2,291 $291K
80053 Comprehensive metabolic panel 1.3% 24,834 20,681 $256K
87086 Culture, bacterial; quantitative colony count, urine 1.3% 24,316 20,098 $250K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.1% 9,346 8,006 $202K
250 more codes
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.0% 651 $198K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,329 $192K
83020 <1% 12,585 $176K
36512 <1% 1,164 $133K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,486 $133K
86850 <1% 22,670 $126K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,830 $123K
83036 Hemoglobin; glycosylated (A1C) <1% 9,453 $120K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 6,852 $104K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,133 $101K
80306 <1% 7,894 $94K
64615 <1% 535 $90K
82728 <1% 9,585 $88K
85027 <1% 18,917 $82K
0001A <1% 2,735 $79K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,870 $78K
0002A <1% 2,337 $76K
J2785 Injection, regadenoson, 0.1 mg <1% 647 $76K
86832 <1% 724 $70K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,986 $68K
86833 <1% 719 $64K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,907 $60K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 3,459 $59K
86922 <1% 3,524 $59K
86901 <1% 22,568 $58K
86900 <1% 22,299 $58K
83735 <1% 7,772 $57K
87536 <1% 1,757 $53K
85045 <1% 10,313 $51K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 684 $48K
82607 <1% 2,884 $48K
83615 <1% 8,449 $47K
J2997 Injection, alteplase recombinant, 1 mg <1% 843 $47K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,246 $46K
74183 <1% 113 $45K
82950 <1% 6,518 $43K
87077 <1% 5,695 $42K
87631 <1% 895 $38K
82746 <1% 2,747 $34K
84443 Thyroid stimulating hormone (TSH) <1% 2,060 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,844 $33K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 429 $33K
84466 <1% 1,958 $32K
80076 <1% 4,353 $29K
73610 <1% 2,126 $29K
78451 <1% 385 $27K
82570 <1% 6,042 $27K
83970 <1% 417 $26K
81001 <1% 7,055 $26K
83880 <1% 905 $25K
81025 <1% 7,009 $24K
73630 <1% 1,792 $24K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 486 $23K
93017 <1% 1,233 $22K
59025 Fetal non-stress test <1% 4,345 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 408 $21K
83540 <1% 3,281 $21K
82565 <1% 2,894 $18K
80061 Lipid panel <1% 1,034 $18K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 775 $18K
84156 <1% 5,823 $18K
87522 Neg quan hep c or qual rna <1% 528 $17K
87186 <1% 2,182 $17K
77067 Screening mammography, bilateral, including computer-aided detection <1% 346 $17K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 540 $16K
31231 <1% 81 $14K
84450 <1% 2,003 $14K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 98 $13K
84484 <1% 1,392 $13K
G0378 Hospital observation service, per hour <1% 114 $13K
85610 <1% 3,291 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,603 $13K
82043 <1% 3,053 $13K
95886 <1% 607 $12K
80197 <1% 2,213 $12K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 247 $12K
83550 <1% 1,583 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 955 $11K
91320 <1% 84 $10K
82977 <1% 1,756 $10K
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg <1% 14 $10K
85007 <1% 2,356 $10K
84439 <1% 1,121 $9K
82105 <1% 663 $9K
86780 <1% 510 $9K
73502 <1% 708 $9K
80069 <1% 1,676 $9K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 49 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 58 $8K
70551 Magnetic resonance imaging, brain; without contrast material <1% 61 $8K
36455 <1% 44 $7K
73564 <1% 439 $7K
86160 <1% 569 $7K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 456 $6K
71046 Radiologic examination, chest; 2 views <1% 666 $6K
62323 <1% 37 $6K
86902 <1% 2,178 $6K
82951 <1% 780 $6K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 31 $6K
73562 <1% 314 $5K
36415 Collection of venous blood by venipuncture <1% 3,954 $5K
76642 <1% 163 $5K
90686 <1% 288 $4K
83690 <1% 568 $4K
73030 <1% 408 $4K
84702 <1% 324 $4K
94729 <1% 235 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 225 $4K
0003A <1% 125 $4K
73620 <1% 333 $4K
0053A <1% 92 $3K
0124A <1% 90 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 136 $3K
72110 <1% 171 $3K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 64 $3K
82952 <1% 779 $3K
91200 <1% 41 $3K
84681 <1% 209 $3K
86225 <1% 264 $3K
94010 <1% 310 $3K
90480 <1% 85 $3K
92587 <1% 81 $3K
76770 <1% 72 $2K
86677 <1% 118 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,584 $2K
85652 <1% 621 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 171 $2K
84134 <1% 253 $2K
82652 <1% 47 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 63 $2K
92567 <1% 232 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 80 $2K
92557 <1% 81 $2K
94727 <1% 143 $2K
85379 <1% 220 $2K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 14 $2K
51600 <1% 14 $2K
74018 <1% 148 $2K
86140 <1% 715 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 768 $1K
73130 <1% 149 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 31 $1K
95911 <1% 16 $1K
71045 Radiologic examination, chest; single view <1% 250 $1K
86870 <1% 96 $1K
97161 <1% 39 $1K
87340 <1% 116 $1K
73221 <1% 14 $1K
73110 <1% 113 $1K
83883 <1% 101 $1K
36593 <1% 17 $1K
86706 <1% 115 $1K
0051A <1% 30 $1K
85730 <1% 479 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 59 $1K
92588 <1% 29 $1K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 672 $943.95
82248 <1% 203 $928.75
J1644 Injection, heparin sodium, per 1000 units <1% 1,799 $907.90
86803 <1% 72 $904.32
72100 <1% 53 $833.90
86905 <1% 348 $822.96
82172 <1% 49 $821.88
88142 <1% 42 $797.21
70450 Computed tomography, head or brain; without contrast material <1% 12 $778.61
80305 <1% 103 $768.87
86923 <1% 108 $714.31
0072A <1% 20 $680.00
85018 <1% 247 $643.61
0071A <1% 18 $640.00
87070 <1% 50 $630.27
86300 <1% 43 $608.35
99195 <1% 13 $600.66
86256 <1% 64 $564.90
Q3014 Telehealth originating site facility fee <1% 108 $561.51
82784 <1% 62 $548.00
86039 <1% 44 $493.50
81003 <1% 201 $479.78
82390 <1% 63 $459.61
82103 <1% 65 $448.14
83010 <1% 49 $436.32
97162 <1% 14 $434.80
93320 <1% 13 $373.74
70355 <1% 21 $373.16
73590 <1% 41 $370.50
86704 <1% 36 $358.96
87147 <1% 125 $303.94
83525 <1% 30 $303.30
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 37 $303.20
93325 <1% 13 $276.36
81002 <1% 158 $274.72
73560 <1% 16 $238.98
80180 <1% 93 $224.26
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 301 $206.44
72052 <1% 14 $197.68
51797 <1% 14 $177.90
84165 <1% 27 $172.26
72190 <1% 16 $171.80
86038 <1% 16 $168.20
86592 <1% 25 $166.78
86790 <1% 12 $166.77
84460 <1% 29 $162.58
91010 <1% 12 $161.76
51784 <1% 14 $148.20
86200 <1% 12 $146.00
84100 <1% 31 $141.00
95885 <1% 14 $131.00
88304 <1% 12 $101.34
82040 <1% 13 $88.00
J1650 Injection, enoxaparin sodium, 10 mg <1% 20 $79.20
J0690 Injection, cefazolin sodium, 500 mg <1% 100 $78.58
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 425 $76.53
85613 <1% 12 $60.66
86431 <1% 12 $56.10
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,304 $45.11
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,172 $43.60
J2704 Injection, propofol, 10 mg <1% 99 $30.09
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg <1% 240 $29.20
J1030 Injection, methylprednisolone acetate, 40 mg <1% 176 $25.84
85014 <1% 15 $24.29
J2270 Injection, morphine sulfate, up to 10 mg <1% 14 $22.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 208 $19.04
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 871 $13.45
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,430 $13.26
82962 <1% 652 $7.26
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 25 $6.96
G0008 Administration of influenza virus vaccine <1% 15 $4.64
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 41 $0.52
0001U 0% 18 $0.00
86361 0% 504 $0.00
90656 0% 29 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 706 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 319 $0.00
C1769 Guide wire 0% 67 $0.00
G0475 Hiv antigen/antibody, combination assay, screening 0% 73 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 251 $0.00
G9172 Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 12 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 0% 38 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 38 $0.00
74430 0% 14 $0.00
93797 0% 41 $0.00
G9171 Voice functional limitation, current status at therapy episode outset and at reporting intervals 0% 12 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 0% 1,659 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 53 $0.00
P9045 Infusion, albumin (human), 5%, 250 ml 0% 222 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 0% 56 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 0% 13 $0.00
91300 0% 150 $0.00
87799 0% 33 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJONES, REID (COO UAB HEALTH SYSTEM)
Same official

Other billing entities under JONES, REID

Full network →
ProviderLocationPaid
University of Alabama at BirminghamBirmingham, AL$3.22M
University of Alabama at BirminghamBirmingham, AL$2.68M
Pediatric Radiology Associates, PCBirmingham, AL$301K
University of Alabama Health Services Foundation, PCBirmingham, AL$135K
University of Alabama at BirminghamBirmingham, AL$2K
University of Alabama Health Services Foundation, PCBirmingham, AL$162.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.